Hydroxycarbamide Market Outlook: 6.1% CAGR Growth Through 2031
According to a newly published market research report by 24LifeSciences, the global hydroxycarbamide market was valued at USD 226 million in 2024 and is projected to reach USD 338 million by 2031, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period 20252031. Hydroxycarbamide, clinically known as hydroxyurea, is a foundational antineoplastic and antimetabolite...
0 Comments 0 Shares 32 Views 0 Reviews